38
Participants
Start Date
October 28, 2021
Primary Completion Date
February 14, 2023
Study Completion Date
February 14, 2023
AOC 1001
AOC 1001 will be administered by intravenous (IV) infusion.
Placebo
Placebo will be administered by intravenous (IV) infusion.
University of Rochester Medical Center, Rochester
Virginia Commonwealth University, Richmond
University of Florida, Gainesville
Ohio State University, Columbus
Kansas University Medical Center, Kansas City
University of Colorado, Denver
University of California Los Angeles, Los Angeles
Stanford University, Palo Alto
Lead Sponsor
Avidity Biosciences, Inc.
INDUSTRY